Evotec SE (ETR:EVT – Get Free Report) shares were down 0.2% during trading on Wednesday . The company traded as low as €5.07 and last traded at €5.20. Approximately 576,627 shares changed hands during mid-day trading, a decline of 58% from the average daily volume of 1,360,000 shares. The stock had previously closed at €5.21.
Evotec Trading Up 0.3%
The company has a market cap of $960.38 million, a PE ratio of -5.60, a PEG ratio of 0.98 and a beta of 1.05. The stock has a 50 day moving average price of €6.29 and a 200 day moving average price of €6.65.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Featured Stories
- Five stocks we like better than Evotec
- What Is WallStreetBets and What Stocks Are They Targeting?
- A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 12 Analysts Just Raised CrowdStrike Targets—Here’s What They See Coming
- P/E Ratio Calculation: How to Assess Stocks
- Palo Alto Networks Stock Just Pulled Back—Is This a Prime Buy Zone?
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
